Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Agilent Technologies (NY: A )

144.97 +0.42 (+0.29%)
Official Closing Price Updated: 4:10 PM EDT, Oct 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Press Releases about Agilent Technologies

< Previous 1 2 3 4 5 6 7 8 9 Next >
YLCHAT Triumphs on Nasdaq: A Digital Revolution in Financial Integration
Via GlobePRwire
Agilent to Host Analyst and Investor Day on Dec. 17, 2024
From Agilent Technologies Inc.
Via Business Wire
Agilent Completes Acquisition of BIOVECTRA
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces Cash Dividend of 23.6 Cents per Share
From Agilent Technologies Inc.
Via Business Wire
Agilent Unveils Biopharma CDx Services Lab to Accelerate Precision Medicine
From Agilent Technologies Inc.
Via Business Wire
Agilent Technologies Thrives From the Forever Chemicals Crackdown
Agilent Technologies Inc. (NYSE: A) is a diversified global leader in the life sciences, diagnostics and applied chemical markets. 
Via MarketBeat
Agilent Reports Third-Quarter Fiscal Year 2024 Financial Results
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces Innovative J&W 5Q GC/MS Columns for Superior Gas Chromatograph Performance
From Agilent Technologies Inc.
Via Business Wire
Agilent Receives FDA Approval for MAGE-A4 IHC 1F9 pharmDx as a Diagnostic Tool for Use with Newly Approved TCR T-Cell Therapy
From Agilent Technologies Inc.
Via Business Wire
Agilent Acquires Sigsense, Creator of AI-Enabled Lab Operations Technology
From Agilent Technologies Inc.
Via Business Wire
Agilent to Acquire North American CDMO BIOVECTRA
From Agilent Technologies Inc.
Via Business Wire
Agilent to Announce Third-Quarter Fiscal Year 2024 Financial Results Aug. 21
From Agilent Technologies Inc.
Via Business Wire
Agilent Names Bret DiMarco Chief Legal Officer
From Agilent Technologies Inc.
Via Business Wire
Agilent’s ESG Report Highlights Expansion of Solutions to Help Labs Manage Their Environmental Footprint
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces Cutting-Edge Advances in GC/MS and LC/Q-TOF Technology at ASMS 2024
From Agilent Technologies Inc.
Via Business Wire
Agilent Reports Second-Quarter Fiscal Year 2024 Financial Results
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces Hans E. Bishop Has Stepped Down from Board of Directors
From Agilent Technologies Inc.
Via Business Wire
Agilent Unveils the 8850 Gas Chromatograph: A Leap Forward in Analytical Excellence
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces Cash Dividend of 23.6 Cents per Share
From Agilent Technologies Inc.
Via Business Wire
Agilent at ASMS 2024: Driving Scientific Breakthroughs with Unparalleled Mass Spec Solutions
From Agilent Technologies Inc.
Via Business Wire
Agilent to Participate in Jefferies Global Healthcare Conference
From Agilent Technologies Inc.
Via Business Wire
Agilent Presents Solutions Innovation Research Awards to Cornell and Indiana University Researchers
From Agilent Technologies Inc.
Via Business Wire
Agilent to Announce Second-Quarter Fiscal Year 2024 Financial Results May 29
From Agilent Technologies Inc.
Via Business Wire
Padraig McDonnell Assumes Agilent CEO Role
From Agilent Technologies Inc.
Via Business Wire
Agilent Announces the NovoCyte Opteon, a Cutting-Edge Spectral Flow Cytometry Solution
From Agilent Technologies Inc.
Via Business Wire
Agilent Names Simon May to Lead Diagnostics and Genomics Group
From Agilent Technologies Inc.
Via Business Wire
Agilent Receives Scientists' Choice Awards for Sustainability
From Agilent Technologies Inc.
Via Business Wire
Agilent Receives European IVDR Class C Certification for GenetiSure Dx Postnatal Assay
From Agilent Technologies Inc.
Via Business Wire
Agilent Brings Great Science to Life at Analytica 2024
From Agilent Technologies Inc.
Via Business Wire
Agilent at AACR 2024: Empowering Breakthroughs in Cancer Research and Diagnostics
From Agilent Technologies Inc.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.